JCRB1066 KMH-2
Cell information
Cell type:general cells (View Pricing Information)
| JCRB No. | JCRB1066 | Cell Name | KMH-2 |
|---|---|---|---|
| Profile | Human anaplasitc thyroid carcinoma cell line with multidrug resistance, derived from a left cervical tumor with a sligt leukocytosis. | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | M | Age | 71 |
| Identity | available | Tissue for Primary Cancer | thyroid |
| Case history | left cervical tumor with a slight leukocytosis, a biopsy revealed an anaplastic thyroid. | Metastasis | |
| Tissue Metastasized | Genetics | Chromosome No. 92-108. | |
| Life Span | infinite | Crisis PDL | |
| Morphology | spindle shaped cells with giant cells | Character | doubling time is 58 hours and multidrug registance. |
| Classify | tumor | Established by | Sekiguchi,K. et. al. |
| Registered by | Sekiguchi,K. | Regulation for Distribution | no |
| Comment | Year | 2003 | |
| Medium | 1 to 1 mixture of Dulbecco's modified Eagle's medium and RPMI1640 medium with 10% heat inactivated feta; bovine serum. | Methods for Passages | Cells are harvested after treatment with 0.25% trypsin. |
| Cell Number on Passage | 10^4 cell/ml | Race | Japanese |
| CO2 Conc. | 5 % | Tissue Sampling | cervical tumor |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:11686581 | Biological characteristics and chemosensitivity profile of four human anaplastic thyroid carcinoma cell lines. Sekiguchi M,Shiroko Y,Arai T,Kishino T,Sugawara I,Kusakabe T,Suzuki T,Yamashita T,Obara T,Ito K,Hasumi K Biomed Pharmacother. 2001 Oct;55(8):466-74 |
| Images |
|---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
| Movies |
|---|
|
|
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB1066 | Cell Name | |
|---|---|---|---|
| LOT No. | 01302004 | Lot Specification | distribution |
| Medium | 1 : 1 mixture of Dulbecco's modified Eagle's medium and RPMI1640 medium with 10% heat-inactivated fetal bovine serum (FBS Lot; GIBCO 3762782S) | Temperature | 37 C |
| Cell Density at Seeding | 4 - 10 x 10^4 cells/ml | Methods for Passages | 0.25% trypsin |
| Doubling Time | 1.1 - 1.5 days | Cell Number in Vial (cells/1ml) | 7.4 x 10^5 |
| Viability at cell freezing (%) | 93.7 | Antibiotics Used | free |
| Passage Number | P278 | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD, AST. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% heat-inactivated FBS in DMEM:RPMI1640 = 1:1 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB1066 | Cell Name | KMH-2 |
|---|---|---|---|
| LOT No. | 04192022 | Lot Specification | distribution |
| Medium | 1 : 1 mixture of Dulbecco's modified Eagle's medium (GIBCO,Cat No.11885-084) and RPMI1640 medium ( GIBCO,Cat No.11875-093) with 10% heat-inactivated fetal bovine serum (Biowest cat.No.S1820-500 LotNo.S09336S1820) | Temperature | 37 C |
| Cell Density at Seeding | 1.07.-6.61x10^4 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with 0.25%trypsin(GIBCO) and 0.02% EDTA. |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 1.41x10^6 |
| Viability at cell freezing (%) | 94.7 | Antibiotics Used | free |
| Passage Number | p279 | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NT |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:12,13 D13S317:9 D7S820:11 D16S539:9,12 VWA:14,15 TH01:9 AM:X,Y TPOX:8,11 CSF1PO:10,11 |
| Adhesion | Yes | Exoteric Gene | NT |
| Medium for Freezing | BAMBANKER(LYMPHOTEC Inc.,CS-02-001,NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 90.7 | Additional information |
| Images |
|---|
![]() ![]() ![]() ![]() ![]() ![]() |


























